Strain dependent effects of prenatal stress on gene expression in the rat hippocampus

Physiology and Behavior

Volumn 104, Issue 2, 2011, Pages 334-339

  Neeley, Eric W ^a   Berger, Ralph ^a   Koenig, James I ^c   Leonard, Sherry ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Bdnf; Chrna7; Grin2b; Nr3c1; Prenatal stress; Rat model; Schizophrenia; Strain difference; Tnf

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BUNGAROTOXIN RECEPTOR; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; TUMOR NECROSIS FACTOR ALPHA;

ACUTE STRESS; ARTICLE; COGNITION; CONTROLLED STUDY; FISCHER 344 RAT; GENE EXPRESSION; GENETIC VARIABILITY; HIPPOCAMPUS; IMMOBILIZATION STRESS; IMMUNITY; LEWIS RAT; NONHUMAN; PERINATAL PERIOD; PRENATAL STRESS; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SPRAGUE DAWLEY RAT; STRESS;

ADRENAL CORTEX HORMONES; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HIPPOCAMPUS; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RADIOIMMUNOASSAY; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NICOTINIC; RNA, MESSENGER; SPECIES SPECIFICITY; STRESS, PSYCHOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79958864774     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.02.032     Document Type: Article

References (73)

1. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait - evidence from a meta-analysis of twin studies. Arch Gen Psych 2003, 60:1187-1192.
2. Owen M.J., Williams H.J., O'Donovan M.C. Schizophrenia genetics: advancing on two fronts. Curr Opin Gen Develop 2009, 19:266-270.
3. Freedman R., Leonard S., Olincy A., Kaufmann C.A., Malaspina D., Cloninger C.R., et al. Evidence for the multigenic inheritance of schizophrenia. Am J Med Genet 2001, 105:794-800.
4. Baron M. Genetics of schizophrenia and the new millennium: progress and pitfalls. Am J Hum Gen 2001, 68:299-312.
5. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005, 10:40-68.
6. Angelucci F., Brene S., Mathe A.A. BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry 2005, 10:345-352.
7. Chen D.C., Wang J., Wang B., Yang S.C., Zhang C.X., Zheng Y.L., et al. Decreased levels of serum brain-derived neurotrophic factor in drug-naive first-episode schizophrenia: relationship to clinical phenotypes. Psychopharmacology 2009, 207:375-380.
8. Coyle J.T., Tsai G., Goff D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann NY Acad Sci 2003, 1003:318-327.
9. Adams C.E., Stevens K.E. Evidence for a role of nicotinic acetylcholine receptors in schizophrenia. Front Biosci 2007, 12:4755-4772.
10. Leonard S., Adler L.E., Benhammou K., Berger R., Breese C.R., Drebing C., et al. Smoking and mental illness. Pharmacol Biochem Behav 2001, 70:561-570.
11. Farber N.B. The NMDA receptor hypofunction model of psychosis. Ann NY Acad Sci 2003, 1003:119-130.
12. Kumari V., Postma P. Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev 2005, 29:1021-1034.
13. Leonard S., Mexal S., Freedman R. Smoking, genetics and schizophrenia: evidence for self medication. J Dual Diag 2007, 3:43-59.
14. McClure R.K., Lieberman J.A. Neurodevelopmental and neurodegenerative hypotheses of schizophrenia: a review and critique. Curr Opin Psychiatry 2003, 16:S15-S28.
15. Van Os J., Selten J.P. Prenatal exposure to maternal stress and subsequent schizophrenia. The May 1940 invasion of The Netherlands. Br J Psychiatry 1998, 172:324-326.
16. King S., Laplante D.P. The effects of prenatal maternal stress on children's cognitive development: Project Ice Storm. Stress 2005, 8:35-45.
17. Mednick S.A., Huttunen M.O., Machon R.A. Prenatal influenza infections and adult schizophrenia. Schizophr Bull 1994, 20:263-267.
18. Howes O.D., McDonald C., Cannon M., Arseneault L., Boydell J., Murray R.M. Pathways to schizophrenia: the impact of environmental factors. Int J Neuropsychopharmacol 2004, 7(Suppl 1):S7-S13.
19. Freedman R., Adams C.E., Adler L.E., Bickford P.C., Gault J., Harris J.G., et al. Inhibitory neurophysiological deficit as a phenotype for genetic investigation of schizophrenia. Am J Med Genet 2000, 97:58-64.
20. Braff D.L., Freedman R., Schork N.J., Gottesman I.I. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull 2007, 33:21-32.
21. Dawe G.S., Hwang E.H.J., Tan C.H. Pathophysiology and animal models of schizophrenia. Ann Acad Med Singapore 2009, 38:425-430.
22. Koenig J.I., Elmer G.I., Shepard P.D., Lee P.R., Mayo C., Joy B., et al. Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. Behav Brain Res 2005, 156:251-261.
23. Koenig J.I., Kirkpatrick B., Lee P. Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology 2002, 27:309-318.
24. Markham J.A., Koenig J.I. Prefrontal neuronal architecture is disrupted in the rat prenatal stress model of schizophrenia. Schizophr Bull 2009, 35:137.
25. Lee P.R., Brady D.L., Shapiro R.A., Dorsa D.M., Koenig J.I. Prenatal stress generates deficits in rat social behavior: Reversal by oxytocin. Brain Res 2007, 1156:152-167.
26. Kinnunen A.K., Koenig J.I., Bilbe G. Repeated variable prenatal stress alters pre- and postsynaptic gene expression in the rat frontal pole. J Neurochem 2003, 86:736-748.
27. Sternberg E.M., Young W.S., Bernardini R., Calogero A.E., Chrousos G.P., Gold P.W., et al. A central nervous-system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Nat Acad Sci 1989, 86:4771-4775.
28. Dhabhar F.S., McEwen B.S., Spencer R.L. Stress-response, adrenal-steroid receptor levels and corticosteroid-binding globulin levels - a comparison between Sprague-Dawley, Fischer-344 and Lewis rats. Brain Res 1993, 616:89-98.
29. Dhabhar F.S., Miller A.H., McEwen B.S., Spencer R.L. Differential activation of adrenal-steroid receptors in neural and immune tissues of Sprague-Dawley, Fischer-344, and Lewis rats. J Neuroimmunol 1995, 56:77-90.
30. Moncek F.F., Kvetnansky R.F, Jezova D. Differential responses to stress stimuli of Lewis and Fischer rats at the pituitary and adrenocortical level. Endocr Regul 2001, 35:35-41.
31. Kosten T.A., Ambrosio E. HPA axis function and drug addictive behaviors: insights from studies with Lewis and Fischer 344 inbred rats. Psychoneuroendocrinology 2002, 27:35-69.
32. Bogerts B., Meertz E., Schonfeldtbausch R. Basal ganglia and limbic system pathology in schizophrenia - a morphometric study of brain volume and shrinkage. Arch Gen Psych 1985, 42:784-791.
33. Heckers S., Konradi C. Hippocampal neurons in schizophrenia. J Neural Transm 2002, 109:891-905.
34. McEwen B.S., Magarinos A.M. Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum Psychopharmacol 2001, 16:S7-S19.
35. Maroun M., Richter-Levin G. Exposure to acute stress blocks the induction of long-term potentiation of the amygdala-prefrontal cortex pathway in vivo. J Neurosci 2003, 23:4406-4409.
36. Alfonso J., Frasch A.C., Flugge G. Chronic stress, depression and antidepressants: effects on gene transcription in the hippocampus. Rev Neurosci 2005, 16:43-56.
37. Radonic A., Thulke S., Mackay I.M., Landt O., Siegert W., Nitsche A. Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 2004, 313:856-862.
38. Simon P. Q-Gene: processing quantitative real-time RT-PCR data. Bioinformatics 2003, 19:1439-1440.
39. Bogoch Y., Biala Y.N., Linial M., Weinstock M. Anxiety induced by prenatal stress is associated with suppression of hippocampal genes involved in synaptic function. J Neurochem 2007, 101:1018-1030.
40. de Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005, 6:463-475.
41. Gomez F., Lahmame A., deKloet E.R., Armario A. Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level. Neuroendocrinology 1996, 63:327-337.
42. Jongen-Relo A.L., Pothuizen H.H.J., Feldon J., Pryce C.R. Comparison of central corticosteroid receptor expression in male Lewis and Fischer rats. Brain Res 2002, 953:223-231.
43. Kabbaj M., Yoshida S., Numachi Y., Matsuoka H., Devine D.P., Sato M. Methamphetamine differentially regulates hippocampal glucocorticoid and mineralocorticoid receptor rnRNAs in Fischer and Lewis rats. Mol Brain Res 2003, 117:8-14.
44. Smith C.C., Omeljaniuk R.J., Whitfield H.J., Aksentijevich S., Fellows M.Q., Zelazowska E., et al. Differential mineralocorticoid (type 1) and glucocorticoid (type 2) receptor expression in Lewis and Fischer rats. Neuroimmunomodulation 1994, 1:66-73.
45. Numachi Y., Yoshida S., Toda S., Matsuoka H., Sato M. Two inbred strains of rats, Fischer 344 and Lewis, showed differential behavior and brain expression of corticosterone receptor mRNA induced by methamphetamine. Ann NY Acad Sci 2000, 914:33-45.
46. Malenka R.C., Bear M.F. LTP and LTD: an embarrassment of riches. Neuron 2004, 44:5-21.
47. Yang C.H., Huang C.C., Hsu K.S. Behavioral stress enhances hippocampal CA1 long-term depression through the blockade of the glutamate uptake. J Neurosci 2005, 25:4288-4293.
48. Liu L., Wong T.P., Pozza M.F., Lingenhoehl K., Wang Y., Sheng M., et al. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 2004, 304:1021-1024.
49. Izumi Y., Auberson Y.P., Zorumski C.F. Zinc modulates bidirectional hippocampal plasticity by effects on NMDA receptors. J Neurosci 2006, 26:7181-7188.
50. Marketon J.I.W., Glaser R. Stress hormones and immune function. Cell Immunol 2008, 252:16-26.
51. Padgett D.A., Glaser R. How stress influences the immune response. Trends Immunol 2003, 24:444-448.
52. Jacque C., Thurin J.M. Stress, immunity and nervous system physiology. M S Med Sci 2002, 18:1160-1166.
53. Anisman H., Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann Med 2003, 35:2-11.
54. Dunn A.J., Wang J.P., Ando T. Effects of cytokines on cerebral neurotransmission - comparison with the effects of stress. Adv Exp Med Biol 1999, 461:117-127.
55. Bartolomucci A., Palanza P., Parmigiani S., Pederzani T., Merlot E., Neveu P.J., et al. Chronic psychosocial stress down-regulates central cytokines mRNA. Brain Res Bull 2003, 62:173-178.
56. Pickering M., Cumiskey D., O'Connor J.J. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 2005, 90:663-670.
57. Stellwagen D., Beattie E.C., Seo J.Y., Malenka R.C. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 2005, 25:3219-3228.
58. Cheng B., Christakos S., Mattson M.P. Tumor necrosis factors protect neurons against metabolic excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 1994, 12:139-153.
59. Barger S.W., Horster D., Furukawa K., Goodman Y., Krieglstein J., Mattson M.P. Tumor-necrosis-factor-alpha and tumor-necrosis-factor-beta protect neurons against amyloid beta-peptide toxicity - evidence for involvement of a kappa-B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Nat Acad Sci 1995, 92:9328-9332.
60. Fukuchi M., Tsuda M. Involvement of the 3'-untranslated region of the brain-derived neurotrophic factor gene in activity-dependent mRNA stabilization. J Neurochem 2010, 115:1222-1233.
61. Chao H.M., Sakai R.R., Ma L.Y., Mcewen B.S. Adrenal steroid regulation of neurotrophic factor expression in the rat hippocampus. Endocrinology 1998, 139:3112-3118.
62. Schaaf M.J.M., de Jong J., de Kloet E.R., Vreugdenhil E. Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Res 1998, 813:112-120.
63. Fuchikami M., Morinobu S., Kurata A., Yamamoto S., Yamawaki S. Single immobilization stress differentially alters the expression profile of transcripts of the brain-derived neurotrophic factor (BDNF) gene and histone acetylation at its promoters in the rat hippocampus. Int J Neuropsychopharmacol 2009, 12:73-82.
64. Molteni R., Calabrese F., Cattaneo A., Mancini M., Gennarelli M., Racagni G., et al. Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine. Neuropsychopharmacology 2009, 34:1523-1532.
65. Marmigere F., Givalois L., Rage F., Arancibia S., Tapia-Arancibia L. Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats. Hippocampus 2003, 13:646-655.
66. Lessmann V., Brigadski T. Mechanisms, locations, and kinetics of synaptic BDNF secretion: an update. Neurosci Res 2009, 65:11-22.
67. Pang P., Teng H., Zaitsev E., Woo N., Sakata K., Zhen S., et al. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 2004, 306:487-491.
68. Schweigreiter R. The dual nature of neurotrophins. Bioessays 2006, 28:583-594.
69. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., et al. Nicotinic acetylcholine receptor alpha 7 subunit is an essential regulator of inflammation. Nature 2003, 421:384-388.
70. de Jonge W.J., Ulloa L. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Brit J Pharmacol 2007, 151:915-929.
71. Parrish W.R., Rosas-Ballina M., Gallowitsch-Pureta M., Ochani M., Ochani K., Yang L.H., et al. Modulation of TNF release by choline requires alpha 7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol Med 2008, 14:567-574.
72. Pavlov V.A., Parrish W.R., Rosas-Ballina M., Ochani M., Puerta M., Qchani K., et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav Immun 2009, 23:41-45.
73. Freedman R., Hall M., Adler L.E., Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 1995, 38:22-33.